Abrdn Healthcare Investors
NYSE:HQHAsset Management
+$0.15 today
- Market cap
- $1.27B
- Beta
- 0.76
- P/E (TTM)
- 4.2
- EPS (TTM)
- $4.72
- Dividend yield
- 11.57%
Volume 0.23M
Average 0.14M
HQH Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Abrdn Healthcare InvestorsNYSE: HQH
Net Receivables · Q4 FY2025 · quarter ended Sep 2025
Net receivables of $13.79K in Q4 FY2025
Q4 FY2025 net receivables was $13.79K. Over 3 fiscal years it compounded at -4.0% a year.
Context
- Net receivables amounted to 0.0% of total assets at the end of Q4 FY2025.
- Net receivables increased in 2 of the last 3 fiscal years.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 2.54M USD
- Year-over-year change
- +412.2%
- 4-year CAGR
- -11.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.54M | +412.2% |
| FY2024 | 2024-12-31 | 495.64K | -92.8% |
| FY2023 | 2023-12-31 | 6.85M | +139.0% |
| FY2022 | 2022-12-31 | 2.87M | -29.1% |
| FY2021 | 2021-12-31 | 4.05M | — |
Net Receivables vs competitors
How HQH compares with its peers on the latest reported figures
- HQH's Sep 2025 net receivables of $13.79K is the 8th highest of the 10 companies compared; the peer median is $23.43M.
- Net receivables amounts to 0.0% of total assets for HQH, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $175.33M | +579.6% | +111.3% | 6.9% | |
| Mar 2026 | $104.4M | -7.5% | +1.1% | 2.3% | |
| Mar 2026 | $35.09M | -49.4% | +3.0% | 1.3% | |
KBDCKayne Anderson BDC, Inc. | Mar 2026 | $24.42M | +39.9% | — | 1.1% |
| Mar 2026 | $23.43M | -59.6% | +6.8% | 0.8% | |
| Mar 2026 | $18.07M | +8.7% | +24.0% | 0.7% | |
| Mar 2026 | $12.74M | -22.2% | -3.8% | 1.6% | |
| Sep 2025 | $13.79K | — | -4.0% | 0.0% | |
| Mar 2026 | $0 | -100.0% | +12.2% | 0.0% | |
| Mar 2026 | $0 | -100.0% | +2.2% | 0.0% | |
| Peer median (excluding HQH) | $23.43M | -22.2% | +4.9% | 1.1% | |
Competitors are the stored peer set for HQH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Abrdn Healthcare Investors
NYSE:HQH
Intrinsic Alpha fair value
Locked
Current Price
$22.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.